Guilian Niu

6.9k citations

19 papers · 5.7k indexed · 6 hit papers · h-index 16

Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions 10
- HER2/EGFR in Cancer Research 2
Immunology top 1%
- Immunotherapy and Immune Responses 3
Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 2
Toxicology top 1%
Pathology and Forensic Medicine top 1%
- Cancer Mechanisms and Therapy 3
Molecular Biology
- PI3K/AKT/mTOR signaling in cancer 4
- Melanoma and MAPK Pathways 3
- Angiogenesis and VEGF in Cancer 3

Co-authors: Hua Yu Richard Jove Drew M. Pardoll Shumin Zhang Tianhong Wang Marcin Kortylewski Maciej Kujawski Richard Heller
Cited by: Oncology Immunology Cancer Research
Partner nations: United States Canada Israel

In The Last Decade

Guilian Niu

19 papers receiving 5.6k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2009 Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
2005 Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
2003 Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
2002 Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
2001 Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

Peers

Countries citing papers authored by Guilian Niu

Since Specialization

Citations

This map shows the geographic impact of Guilian Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guilian Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guilian Niu more than expected).

Fields of papers citing papers by Guilian Niu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guilian Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guilian Niu. The network helps show where Guilian Niu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Guilian Niu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guilian Niu Line = papers co-authored together Guilian Niu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumorsbreakdown → Heehyoung Lee,Andreas Herrmann,Jiehui Deng,Maciej Kujawski,Guilian Niu,Zhiwei Li,Steve J. Forman,Richard Jove,Drew M. Pardoll,Hua Yu	2009	558
2	Signal Transducer and Activator of Transcription 3 Is Required for Hypoxia-Inducible Factor-1α RNA Expression in Both Tumor Cells and Tumor-Associated Myeloid Cells Guilian Niu,Jon Briggs,Jiehui Deng,Yihong Ma,Heehyoung Lee,Marcin Kortylewski,Maciej Kujawski,H. David Kay,W. Douglas Cress,Richard Jove,Hua Yu	2008	151
3	Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors Hyun-Il Cho,Guilian Niu,Norma Bradley,Esteban Celis	2008	15
4	Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter Dayami Lopez,Guilian Niu,Philippe Huber,W. Bradford Carter	2008	58
5	Mechanisms of HER2-Induced Endothelial Cell Retraction W. Bradford Carter,Guilian Niu,Michael D. Ward,Gregory Small,Julianne E. Hahn,Barbara J. Muffly	2007	7
6	Human Epidermal Growth Factor Receptor 2 Regulates Angiopoietin-2 Expression in Breast Cancer via AKT and Mitogen-Activated Protein Kinase Pathways Guilian Niu,W. Bradford Carter	2007	39
7	Stat3 Activity in Melanoma Cells Affects Migration of Immune Effector Cells and Nitric Oxide-Mediated Antitumor Effects Lyudmila G. Burdelya,Maciej Kujawski,Guilian Niu,Bin Zhong,Tianhong Wang,Shumin Zhang,Marcin Kortylewski,Kenneth H. Shain,H. David Kay,Julie Y. Djeu,William S. Dalton,Drew M. Pardoll,Wei Sheng,Hua Yu	2005	114
8	Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathwaysbreakdown → Qing Xu,Jon Briggs,Sungman Park,Guilian Niu,Marcin Kortylewski,Shumin Zhang,Tanya Gritsko,James Turkson,H. David Kay,Gregg L. Semenza,Jin Cheng,Richard Jove,Hua Yu	2005	489
9	Stat3 Is Required for Full Neoplastic Transformation by the Simian Virus 40 Large Tumor Antigen Adina Vultur,Rozanne Arulanandam,James Turkson,Guilian Niu,Richard Jove,Leda Raptis	2005	45
10	Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunitybreakdown → Marcin Kortylewski,Maciej Kujawski,Tianhong Wang,Wei Sheng,Shumin Zhang,Shari Pilon‐Thomas,Guilian Niu,H. David Kay,James J. Mulé,William G. Kerr,Richard Jove,Drew M. Pardoll,Hua Yu	2005	813
11	Role of Stat3 in Regulating p53 Expression and Function Guilian Niu,Kenneth L. Wright,Yihong Ma,Gabriëla Wright,Mei Huang,Rosalyn Irby,Jon Briggs,James G. Karras,W. Douglas Cress,Drew M. Pardoll,Richard Jove,Jiangdong Chen,Hua Yu	2005	332
12	Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cellsbreakdown → Tianhong Wang,Guilian Niu,Marcin Kortylewski,Lyudmila G. Burdelya,Kenneth H. Shain,Shumin Zhang,Raka Bhattacharya,Dmitry I. Gabrilovich,Richard Heller,Domenico Coppola,William S. Dalton,Richard Jove,Drew M. Pardoll,Hua Yu	2003	923
13	[Role of matrix metalloproteinases (MMPs) in tumor invasion and metastasis: serial studies on MMPs and TIMPs]. Weigang Fang,Hongmei Li,Lingling Kong,Guilian Niu,Qing Gao,Kexiang Zhou,Jie Zheng,Bingquan Wu	2003	12
14	Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisbreakdown → Guilian Niu,Kenneth L. Wright,Mei Huang,Lanxi Song,Eric B. Haura,James Turkson,Shumin Zhang,Tianhong Wang,Dominic Sinibaldi,Domenico Coppola,Richard Heller,Lee M. Ellis,James G. Karras,Jacqueline Bromberg,Drew M. Pardoll,Richard Jove,Hua Yu	2002	1019
15	Roles of activated Src and Stat3 signaling in melanoma tumor cell growth Guilian Niu,Tammy Bowman,Mei Huang,Steven C. Shivers,Douglas S. Reintgen,Adil Daud,Alfred E. Chang,Alan J. Kraker,Richard Jove,Hua Yu	2002	355
16	Inhibition of Bcr–Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells Mei Huang,Jay F. Dorsey,PK Epling-Burnette,Ramadevi Nimmanapalli,Terry H. Landowski,Linda Mora,Guilian Niu,Dominic Sinibaldi,Fanqi Bai,Alan J. Kraker,Hua Yu,Lynn C. Moscinski,Sheng Wei,Julie Y. Djeu,William S. Dalton,Kapil N. Bhalla,Thomas P. Loughran,Jie Wu,Richard Jove	2002	102
17	Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cellsbreakdown → Roy Garcia,Tammy Bowman,Guilian Niu,Hua Yu,Sue Minton,Carlos Muro‐Cacho,Charles E. Cox,Robert E. Falcone,Rita Fairclough,Sarah J. Parsons,Andy Laudano,Aviv Gazit,Alexander Levitzki,Alan J. Kraker,Richard Jove	2001	654
18	Bing De Ling, a Chinese Herbal Formula, Stimulates Multifaceted Immunologic Responses in Mice Guilian Niu,Jun Tan,Joel G. Turner,Jeffrey G. Brabham,Lyudmila G. Burdelya,Brian Crucian,Helga Wall-Apelt,Ruan-Jin Zhao,Hua Yu	2000	5
19	Interleukin-12 cDNA skin transfection potentiates human papillomavirus E6 DNA vaccine-induced antitumor immune response Jun Tan,Ning-Sun Yang,Joel G. Turner,Guilian Niu,H. F. Maassab,Jian Sun,M. Louise Herlocher,Alfred E. Chang,Hua Yu	1999	28

About Guilian Niu

Guilian Niu is a scholar working on Oncology, Cancer Research and Immunology, having authored 19 papers that have together received 5.7k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (10 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer Mechanisms and Therapy (3 papers), Melanoma and MAPK Pathways (3 papers), Immunotherapy and Immune Responses (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (3.6k citations), Immunology (2.0k citations) and Cancer Research (1.1k citations). Guilian Niu has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include Hua Yu, Richard Jove, Drew M. Pardoll, Shumin Zhang, Tianhong Wang, Marcin Kortylewski, Maciej Kujawski, Richard Heller, Domenico Coppola and Mei Huang.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact